Daniel A. Carestio is the President and CEO of STERIS plc, having taken over the role in July 2021 after a successful tenure as Chief Operating Officer. With a solid background in operations, Daniel has been integral to STERIS's growth...
Daniel A. Carestio is the President and CEO of STERIS plc, having taken over the role in July 2021 after a successful tenure as Chief Operating Officer. With a solid background in operations, Daniel has been integral to STERIS's growth since he joined the company in 1997. Prior to becoming CEO, he served in various senior leadership positions, including Senior Vice President of Sterilization and Disinfection. His leadership style focuses on performance and aligning company goals with long-term shareholder values. Under his guidance, STERIS has continuously generated increasing cash flows, demonstrating robust financial health. Interestingly, as of 2023, Daniel's total compensation reached approximately $950,776, heavily weighted towards performance-based incentives—which reflects the company's strong performance metrics. Daniel also has a notable track record in insider trading with substantial transactions amounting to millions of dollars, indicating confidence in STERIS’s prospects. He continues to navigate the company through the evolving healthcare landscape, making strategic decisions that shape its future.